-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk: The oral formulation of the weight loss drug simeglutide has been approved in the US and is the first oral glucagon-like peptide-1 drug for weight management.

Zhitongcaijing·12/22/2025 22:57:02
Listen to the news
Novo Nordisk: The oral formulation of the weight loss drug simeglutide has been approved in the US and is the first oral glucagon-like peptide-1 drug for weight management.